This study, published in Cell, demonstrates that engineering T-cells to express both a Chimeric Antigen Receptor (CAR) and a T-cell Receptor (TCR) can improve their ability to distinguish between ...

A phase I study of a next-generation CAR T cell therapy showed a 52 percent complete remission rate for patients with relapsed/refractory lymphoma. A next-generation "armored" CAR T cell therapy ...

Cemacabtagene ansegedleucel, an allogeneic chimeric antigen receptor (CAR) T-cell therapy, is being investigated in relapsed/refractory large B-cell lymphoma. The investigational allogeneic ...

On a graph illustrating B cell counts over time after CAR T-cell therapy, the depletion appeared as a “deep, narrow valley,” dropping virtually to zero shortly after initiating therapy ...

CARGO Therapeutics will focus on developing CRG-023, a tri-specific CAR T-cell therapy, with a phase 1 study planned for 2025. The FIRCE-1 trial investigating the CAR T-cell therapy firi-cel in ...

Co-founder Burnie Burns has bought the studio the studio back from Warner Bros. Discovery. Co-founder Burnie Burns has bought the studio the studio back from Warner Bros. Discovery. Charles ...

It was announced on the Morning Somewhere podcast by Burnie Burns and Ashley that they have acquired Rooster Teeth. In the Press Release, Burnie mentions that he is happy to be able to “return ...

Rooster Teeth co-founder Burnie Burns announced Wednesday that he has acquired “the Rooster Teeth brand and much of its remaining assets” through his independent company, Box Canyon Productions.

Burnie Burns started rooster teeth in 2003. Now, he's acquired the company through his new venture, Box Canyon Productions. The deal includes plans to revive some of Rooster Teeth's classic shows ...

On Wednesday, Burnie Burns — one of Rooster Teeth’s co-founders — announced that his independent company, Box Canyon Productions, has acquired the Rooster Teeth brand and its remaining ...

Rooster Teeth co-founder Burnie Burns announced Wednesday that he has acquired “the Rooster Teeth brand and much of its remaining assets” through his independent company, Box Canyon Productions. The ...

Scientists push CAR T cell therapy beyond blood cancers, unlocking potential for targeting solid tumors with enhanced delivery, resilience, and precision in the face of tough obstacles.